Literature DB >> 27835725

Bright Light Therapy as Augmentation of Pharmacotherapy for Treatment of Depression: A Systematic Review and Meta-Analysis.

Thomas M Penders1,2, Cornel N Stanciu2, Alexander M Schoemann3, Philip T Ninan2, Richard Bloch2, Sy A Saeed2.   

Abstract

BACKGROUND: Bright light therapy has demonstrated efficacy and is an accepted treatment for seasonal depression. It has been suggested that bright light therapy may have efficacy in nonseasonal depressions. Also, there is evidence that bright light therapy may improve responsiveness to antidepressant pharmacotherapy. DATA SOURCES: We searched PubMed/MEDLINE, PsycINFO, PsycARTICLES, CINAHL, EMBASE, Scopus, and Academic OneFile for English-language literature published between January 1998 and April 2016, using the keywords bright light therapy AND major depression, bright light therapy AND depress*, bright light therapy AND bipolar depression, bright light therapy AND affective disorders, circadian rhythm AND major depression, circadian rhythm AND depress*, and circadian rhythm AND affective disorder. STUDY SELECTION AND DATA EXTRACTION: Studies that reported randomized trials comparing antidepressant pharmacotherapy with bright light therapy ≥ 5,000 lux for ≥ 30 minutes to antidepressant pharmacotherapy without bright light therapy for the treatment of nonseasonal depression were included. Studies of seasonal depression were excluded. Following review of the initial 112 returns, 2 of the authors independently judged each trial, applying the inclusionary and exclusionary criteria. Ten studies were selected as meeting these criteria. Subjects in these studies were pooled using standard techniques of meta-analysis.
RESULTS: Ten studies involving 458 patients showed improvement using bright light therapy augmentation versus antidepressant pharmacotherapy alone. The effect size was similar to that of other accepted augmentation strategies, roughly 0.5.
CONCLUSIONS: Analysis of pooled data from randomized trials provides evidence for the efficacy of use of bright light therapy ≥ 5,000 lux for periods ≥ 30 minutes when used as augmentation to standard antidepressant pharmacotherapy in the treatment of major depressive disorder and bipolar depression without a seasonal pattern. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27835725     DOI: 10.4088/PCC.15r01906

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


  12 in total

1.  Luxotonic signals in human prefrontal cortex as a possible substrate for effects of light on mood and cognition.

Authors:  Shai Sabbah; Michael S Worden; Dimitrios D Laniado; David M Berson; Jerome N Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-06       Impact factor: 12.779

2.  Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Raymond W Lam; Minnie Y Teng; Young-Eun Jung; Vanessa C Evans; John F Gottlieb; Trisha Chakrabarty; Erin E Michalak; Jill K Murphy; Lakshmi N Yatham; Dorothy K Sit
Journal:  Can J Psychiatry       Date:  2019-12-12       Impact factor: 4.356

3.  Sociodemographic, Health and Lifestyle, Sampling, and Mental Health Determinants of 24-Hour Motor Activity Patterns: Observational Study.

Authors:  Sonia Difrancesco; Harriëtte Riese; Kathleen R Merikangas; Haochang Shou; Vadim Zipunnikov; Niki Antypa; Albert M van Hemert; Robert A Schoevers; Brenda W J H Penninx; Femke Lamers
Journal:  J Med Internet Res       Date:  2021-02-17       Impact factor: 5.428

4.  Efficacy of light therapy on nonseasonal depression among elderly adults: a systematic review and meta-analysis.

Authors:  Chun-Hung Chang; Chieh-Yu Liu; Shaw-Ji Chen; Hsin-Chi Tsai
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-14       Impact factor: 2.570

5.  The Suprachiasmatic Nucleus Regulates Anxiety-Like Behavior in Mice.

Authors:  Chelsea A Vadnie; Kaitlyn A Petersen; Lauren A Eberhardt; Mariah A Hildebrand; Allison J Cerwensky; Hui Zhang; Jennifer N Burns; Darius D Becker-Krail; Lauren M DePoy; Ryan W Logan; Colleen A McClung
Journal:  Front Neurosci       Date:  2022-01-20       Impact factor: 4.677

6.  Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults.

Authors:  Timothy M Brown; George C Brainard; Christian Cajochen; Charles A Czeisler; John P Hanifin; Steven W Lockley; Robert J Lucas; Mirjam Münch; John B O'Hagan; Stuart N Peirson; Luke L A Price; Till Roenneberg; Luc J M Schlangen; Debra J Skene; Manuel Spitschan; Céline Vetter; Phyllis C Zee; Kenneth P Wright
Journal:  PLoS Biol       Date:  2022-03-17       Impact factor: 8.029

Review 7.  The Effects of Light and the Circadian System on Rhythmic Brain Function.

Authors:  Charlotte von Gall
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

8.  Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US Veterans with TBI. A prospective, open-label, single-arm trial.

Authors:  Jonathan E Elliott; Alisha A McBride; Nadir M Balba; Stanley V Thomas; Cassandra L Pattinson; Benjamin J Morasco; Andrea Wilkerson; Jessica M Gill; Miranda M Lim
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.752

9.  The Role of Daylight for Humans: Gaps in Current Knowledge.

Authors:  Mirjam Münch; Anna Wirz-Justice; Steven A Brown; Thomas Kantermann; Klaus Martiny; Oliver Stefani; Céline Vetter; Kenneth P Wright; Katharina Wulff; Debra J Skene
Journal:  Clocks Sleep       Date:  2020-02-28

Review 10.  Multi-Level Processes and Retina-Brain Pathways of Photic Regulation of Mood.

Authors:  Julia Maruani; Pierre A Geoffroy
Journal:  J Clin Med       Date:  2022-01-16       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.